Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE study.

Autor:	Cunningham, Evan B.1 ecunningham@Kirby.Unsw.Edu.Au, Hajarizadeh, Behzad1, Dalgard, Olav2, Amin, Janaki1, Hellard, Margaret3, Foster, Graham R.4, Bruggmann, Philip5, Conway, Brian6, Backmund, Markus7, Robaeys, Geert8,9,10, Swan, Tracy11, Marks, Philippa S.1, Quiene, Sophie1, Applegate, Tanya L.1, Weltman, Martin12, Shaw, David13, Dunlop, Adrian14, Bruneau, Julie15, Midgard, Håvard2, Bourgeois, Stefan16
Zdroj:	BMC Infectious Diseases. 6/13/2017, Vol. 17, p1-12. 12p. 1 Diagram, 5 Charts, 2 Graphs.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu